Culture Media for Borrelia Burgdorferi Sensu Lato

The main purpose of this study is to compare effectiveness of two different culture media for cultivation of Borrelia burgdorferi sensu lato from skin specimens obtained from patients with erythema migrans.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Erythema Migrans Bacterial Infections Bacterial Infections and Mycoses Borrelia Infections Glossitis Glossitis, Benign Migratory Gram-Negative Bacterial Infections Infections Lyme Disease Mouth Diseases Spirochaetales Infections Stomatognathic Diseases Tick-Borne Diseases Tongue Diseases Vector Borne Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UMC Ljubljana, Department of Infectious Diseases

Ljubljana, 1525, Slovenia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

erythema migrans in patients > 18 years

Exclusion criteria

pregnancy or lactation
taking antibiotic with antiborrelial activity within 10 days
erythema migrans localized on face or neck

Each patient (235 subjects) provided two skin samples (470 skin samples).

Treatment and study plan

MKP media

Other

one half of skin specimen was put in MKP media

BSK-H media

Other

one half of skin specimen was put in BSK-H media

Primary outcomes

Detection of Borrelia Burgdorferi Sensu Lato by Microscopy in Dark Field (Positive vs. Negative)

Time frame: weekly examination during 9 weeks of cultivating for individual specimen

number of erythema migrans skin samples with Borrelia Burgdorferi sensu lato detected by Microscopy in Dark Field

Sponsors and collaborators

Lead sponsor

University Medical Centre Ljubljana

Other

Collaborators

University of Ljubljana School of Medicine, Slovenia

Registry information

Official study title

Comparison of Two Culture Media for Cultivation of Borrelia Burgdorferi Sensu Lato

Important dates

Study start: 2013
Primary completion: 2014
First posted: May 23, 2014
Registry last updated: Jun 30, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed